Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-03-26

Clinical Trial Update: Genetic Variation in the Transporters and Hypoglycemic Agents

View source ↗

Summary

This clinical trial update examines how genetic variation in drug transporters affects responses to hypoglycemic medications in people with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypoglycemic agents (general)

Snippet

Sponsor: Ajou University School of Medicine | Conditions: Type 2 Diabetes | Status: UNKNOWN